Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
682 Leser
Artikel bewerten:
(2)

GreenBank Capital Inc.: GreenBank Announces that Richard Beresford has Joined Its Board of Directors

Finanznachrichten News

This news release is not for distribution or dissemination in the United States of America

TORONTO, ON / ACCESSWIRE / April 23, 2020 / GreenBank Capital Inc. (CSE:GBC)(OTCMKTS:GRNBF)(FRA:2TL) ("GreenBank or the Company") is very pleased to announce that Richard Beresford has joined its Board of Directors, having been voted onto the Board by the shareholders of the Company at the recent Annual General Meeting held on Wednesday 8th April 2020.

Mr. Beresford is an entrepreneurial corporate lawyer with over 25 years' experience in the City of London. He is the driving force behind McCarthy Denning, a next-generation law firm, providing a radical new approach to the delivery of high-quality legal advice. The firm has international reach and experience and offers a full range of specialist expertise including employment, property, banking and debt finance, corporate, corporate finance, litigation, tax, competition and EU law. Richard has clients across several continents and brings a wealth of knowledge and experience to the GreenBank Capital Board.

In 2017 Richard co-founded and became non-executive chairman of Rockpool Acquisitions PLC which is listed on the Main Market of the London Stock Exchange. Previously, Richard was a partner with McGuireWoods for over 4 years where he focused on M&A transactions (including those with cross-border elements).

He earned his undergraduate law degree from the University of Warwick, and First Class Honors in his Solicitors Finals Exams at the City of London Polytechnic (now part of the London Metropolitan University).

Mark Wettreich, Chairman of Greenbank Capital said, "We are delighted to welcome Richard to the Board of Directors. His international knowledge and relationships will be invaluable to the Company and together with Terry Pullen helps establish the global perspective which will be critically important in executing GreenBank Capital's strategy".

About GreenBank

GreenBank is a merchant banking business listed on the Canadian Securities Exchange (trading symbols CSE: GBC and OTCMKTS: GRNBF and FRA: 2TL). GreenBank's 100% subsidiary GreenBank Financial Inc. is a merchant bank. GreenBank's portfolio companies comprise equity investments in 11 small cap businesses, namely; 52.5% of Blockchain Evolution Inc, owners of the world's first identification based blockchain, and developers of Xbook a user permissioned and revenue sharing social media platform; 22.6% of Ubique Minerals Limited, a zinc exploration company in Newfoundland, Canada; 47.7% of GBC Grand Exploration Inc, a gold exploration company in Newfoundland, Canada;; 59.5% of Kabaddi Games Inc, developers of a mobile application game based on the sport of Kabaddi;; 19% of Inside Bay Street Corporation, a financial news communications company; 34.8% of Gander Exploration Inc, a minerals exploration company in Newfoundland, Canada; 10% of Reliable Stock Transfer Inc, a Canadian small cap transfer agency; 25% of Buchans Wileys Exploration Inc, a minerals exploration company with interests in Newfoundland, Canada; 19% of Staminier Limited, a United Kingdom Merchant Banking firm, 10% of The Lonsdale Group LLC, a USA based private equity company focused on small cap investments;; and 11.2% of Minfocus Exploration Corp (TSXV: MFX), a mineral exploration company.

For more information please see https://www.GreenBankCapitalinc.com or contact Mark Wettreich at (647) 693 9411 or by email Mark@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc., the raising of additional capital and the future development of the businesses comprising GreenBank's investment portfolio. The forward-looking information is based on certain key expectations and assumptions made by the company's management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GreenBank can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and GreenBank disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: GreenBank Capital Inc.



View source version on accesswire.com:
https://www.accesswire.com/586678/GreenBank-Announces-that-Richard-Beresford-has-Joined-Its-Board-of-Directors

© 2020 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.